Muscle weakness post-COVID: a practical guide for primary care
Open Access
- 28 November 2024
- journal article
- editorial
- Published by Royal College of General Practitioners in British Journal of General Practice
- Vol. 74 (749) , 573-575
Abstract
Since the earliest stages of the pandemic, muscle weakness has been a key symptom described by patients post-COVID infection. Estimated to affect up to 60% of those with long COVID, it can have a profound effect on the ability to carry out activities of daily living.1 Many patients describe a fluctuating pattern to such symptoms, which can be triggered by exercise or fatigue.2 Most of these patients do not receive any muscle-specific investigations and many are told that they are experiencing the impacts of deconditioning or that they have a psychological or functional disorder. Such patients are often prescribed antidepressants or diverted down rehabilitation or psychological support pathways. Although some patients find this helpful, many patients experiencing muscle symptoms do not benefit from such approaches. Two case studies are given in Box 1.Keywords
This publication has 21 references indexed in Scilit:
- The relationship between myasthenia gravis and COVID-19: a systematic reviewThe Egyptian Journal of Neurology, Psychiatry and Neurosurgery, 2022
- Myopathy as a cause of fatigue in long‐term post‐COVID‐19 symptoms: Evidence of skeletal muscle histopathologyEuropean Journal of Neurology, 2022
- The Relationship between Physical Activity and Long COVID: A Cross-Sectional StudyInternational Journal of Environmental Research and Public Health, 2022
- Parsonage-Turner syndrome following COVID-19 vaccination and review of the literatureSurgical Neurology International, 2022
- Skeletal muscle alterations in patients with acute Covid‐19 and post‐acute sequelae of Covid‐19Journal of Cachexia, Sarcopenia and Muscle, 2022
- Acute Transverse Myelitis (ATM):Clinical Review of 43 Patients With COVID-19-Associated ATM and 3 Post-Vaccination ATM Serious Adverse Events With the ChAdOx1 nCoV-19 Vaccine (AZD1222)Frontiers in Immunology, 2021
- Critical illness polyneuropathy and myopathy: a systematic reviewNeural Regeneration Research, 2014
- Myasthenia gravisBMJ, 2012
- Patient Self-management of Chronic Disease in Primary CareJAMA, 2002
- Is primary care essential?The Lancet, 1994